We have located links that may give you full text access.
[Prolonged Secondary Prevention After Venous Thromboembolism].
Deutsche Medizinische Wochenschrift 2018 Februrary
Recent studies: Shortly after discontinuation of the oral anticoagulation (OAC) there is a 2- to 3 fold increase in VTE recurrences. The risk for recurrence is particularly high in VTE events that occurred without provoking risk factor, with minor provoking factors and in cases with persistent risk factors such as active cancer.Guidance document for the categorization of risk factors for VTE: A recent guidance document defined underlying risk factors for the occurrence of VTE and categorized them into three groups. Direct oral anticoagulants (DOACs): For long-term secondary prevention, a reduced dosing regimen of DOACs was found to be effective with a low bleeding risk. Aspirin should no longer be used for secondary prevention of VTE because the efficacy to prevent recurrent events is lower, while there was no difference in the risk of major bleeding.A Traffic light system helps to select the appropriate duration of anticoagulation. Patients are risk stratified into three groups according to their presumed risk of recurrence. For the majority of the patients this leads to a clear decision to stop or continue OAC (green or red traffic light, respectively). In case of prolonged anticoagulation, the use of a reduced dose DOAC regimen may be considered in view of risk-benefit-balancing.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app